Itacitinib is an investigational, selective Janus kinase 1 (JAK1) inhibitor currently under evaluation for its potential to treat various autoimmune diseases, inflammatory conditions, and specific hematologic… Read more
Itacitinib is an investigational, selective Janus kinase 1 (JAK1) inhibitor currently under evaluation for its potential to treat various autoimmune diseases, inflammatory conditions, and specific hematologic malignancies. To support rigorous drug development and pharmaceutical research, this category provides reference standards for Itacitinib, including critical impurities and metabolites necessary for comprehensive analytical testing. Laboratories rely on stable isotope labelled compounds to enhance the precision of their analytical methods, particularly during impurity profiling and quality control workflows where high-sensitivity mass spectrometry is required. By utilizing these high-quality standards, researchers can accurately identify, characterize, and quantify degradation products and drug-related compounds, ensuring regulatory compliance and consistency throughout the pharmaceutical manufacturing and development process.